Menu Back to 7th-DIA-CMC-Forum-in-Japan

Program Committee

  • Noriko  Katori, PhD
    Noriko Katori, PhD Division of Drugs
    National Institute of Health Sciences, Japan
  • Takeshi  Hamaura, PhD
    Takeshi Hamaura, PhD Vice President, CMC Planning Department, Pharmaceutical Technology Division
    Daiichi Sankyo Co., Ltd., Japan
  • Yukio  Hiyama, PhD
    Yukio Hiyama, PhD Visiting Researcher
    National Institute of Health Sciences, Japan
  • Fusashi  Ishikawa, PhD, MSc
    Fusashi Ishikawa, PhD, MSc Director, Formulation Property Research Group, Formulation R&D Laboratories
    Sumitomo Dainippon Pharma Co., Ltd., Japan
  • Yoshihiro  Matsuda, PhD
    Yoshihiro Matsuda, PhD Senior Scientist (for Quality), Pharmacist
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Tomonori  Nakagawa
    Tomonori Nakagawa Production HQ Manufacturing Process Development Department (API)
    Otsuka Pharmaceutical Co., Ltd., Japan
  • Haruhiro  Okuda, PhD
    Haruhiro Okuda, PhD Deputy Director General
    National Institute of Health Sciences, Japan
  • Tomoaki  Sakamoto, PhD
    Tomoaki Sakamoto, PhD Section Chief
    National Institute of Health Sciences, Japan
  • Kazunori  Takagi, PhD
    Kazunori Takagi, PhD Deputy Review Director, Office of Generic Drugs
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Jun  Yamada
    Jun Yamada Senior Manager, Global CMC NCE-Japan & East Asia
    Pfizer Japan Inc., Japan
Load More

Digital Learning Catalog

DIA Learning: 2018 eLearning Soultions
Download